Feature|Videos|November 18, 2026

The Workload Balance in Pharma Between Humans and Agentic Models

The future is agent-first but human when it matters — AI handles repetitive tasks while humans manage exceptions, complexity, and regulatory needs.

Pharmaceutical Executive spoke with Ankit Jain, CEO and founder of Infinitus, about how agentic AI models are being deployed across the pharma and biotech industries. The conversation focused on how these models are helping manage teams more efficiently.

Jain discussed these models have the potential to reshape the industry’s commercial model by providing both field teams and physicians with a wider array of tools and communication options.

He also explained why these models must start delivering results that go beyond just productivity benefits and start delivering broader changes to the industry.

Pharmaceutical Executive: How are agentic models impacting the workload balance between humans and machines?
Ankit Jain: We strongly believe the future of most technology is agent-first, but human when it matters most. The majority of work we do in healthcare — and across many other fields — is repetitive and tedious. We see agents as the first line of defense, with escalation to humans reserved for when you truly need to manage exceptions, dig deeper than agents can today, or navigate regulatory requirements. It’s not one or the other. It’s about ensuring that first line of defense is actually useful — not the annoying IVR systems of the past that everyone either pressed zero on or yelled “agent” at because they simply weren’t helpful.


Related to this article